BRUSSELS, June 23, 2026
Cognivia announced a strategic collaboration with Mayo Clinic to advance the use of behavioral intelligence across clinical research and clinical care. The collaboration combines Cognivia’s behavioral intelligence technology with Mayo Clinic’s expertise in patient care and shared decision-making to address behavioral factors that significantly influence healthcare outcomes. The initial focus will be on patient non-adherence, missed medical appointments, and clinical trial retention, three challenges that continue to affect research quality, healthcare efficiency, and treatment success worldwide. By making patient behavior measurable and actionable, the collaboration aims to help healthcare organizations identify behavioral risks earlier, strengthen patient engagement, and improve both clinical trial performance and routine patient care.
Behavioral Data Could Improve Research Quality and Patient Outcomes
Patient behavior plays a critical role in determining the success of clinical trials, treatment adherence, and long-term health outcomes. While advances in medicine have traditionally focused on biological and clinical data, behavioral factors such as missed visits, medication adherence, protocol compliance, and treatment persistence remain major contributors to variability in research and healthcare delivery. Cognivia’s behavioral intelligence platform is designed to detect these risks earlier, allowing researchers and healthcare providers to implement targeted interventions before non-adherence or disengagement affects study quality or patient outcomes. Earlier identification of behavioral risks may improve clinical trial retention, reduce protocol deviations, minimize operational delays, and support more reliable research data while also helping healthcare providers reduce missed appointments and treatment interruptions in everyday clinical practice.
Collaboration Supports More Predictable Clinical Research
The partnership will specifically examine behavioral drivers that contribute to clinical trial dropout, inconsistent treatment adherence, and appointment compliance. These factors often increase research costs, reduce study efficiency, and create uncertainty in trial results by introducing variability unrelated to the investigational therapy itself. Through behavioral intelligence, researchers may gain earlier visibility into participants who are at risk of leaving a study or failing to follow treatment protocols, allowing proactive engagement strategies that improve retention and study execution. Beyond research, similar behavioral insights may help clinicians identify patients who require additional support to maintain treatment schedules, attend follow-up visits, and adhere to prescribed therapies, ultimately improving the consistency and quality of patient care across healthcare systems.
Advertisement
Behavioral Intelligence Represents a Growing Area of Clinical Innovation
The collaboration highlights the increasing role of behavioral science in modern healthcare and clinical research, where patient engagement is becoming as important as biological response in determining treatment success. According to Cognivia, integrating behavioral intelligence into healthcare workflows could provide organizations with a more complete understanding of patient outcomes by complementing traditional biological and operational data. Mayo Clinic will contribute its expertise in patient-centered care while maintaining its commitment to research, education, and clinical innovation. As healthcare organizations continue to adopt data-driven approaches to improve research efficiency and patient outcomes, the collaboration between Cognivia and Mayo Clinic represents an important step toward incorporating measurable behavioral insights into routine clinical trials, clinical operations, and patient care, supporting more personalized interventions and more predictable healthcare outcomes.
Source: Cognivia press release
